These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 10648603)

  • 1. The survival function of the Bcr-Abl oncogene is mediated by Bad-dependent and -independent pathways: roles for phosphatidylinositol 3-kinase and Raf.
    Neshat MS; Raitano AB; Wang HG; Reed JC; Sawyers CL
    Mol Cell Biol; 2000 Feb; 20(4):1179-86. PubMed ID: 10648603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation of interleukin-3-dependent cells without participation of Stat5/bcl-xL: cooperation of akt with raf/erk leads to p65 nuclear factor kappaB-mediated antiapoptosis involving c-IAP2.
    Gelfanov VM; Burgess GS; Litz-Jackson S; King AJ; Marshall MS; Nakshatri H; Boswell HS
    Blood; 2001 Oct; 98(8):2508-17. PubMed ID: 11588049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of constitutively active Raf-1 in the mitochondria restores antiapoptotic and leukemogenic potential of a transformation-deficient BCR/ABL mutant.
    Salomoni P; Wasik MA; Riedel RF; Reiss K; Choi JK; Skorski T; Calabretta B
    J Exp Med; 1998 Jun; 187(12):1995-2007. PubMed ID: 9625759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of phosphorylation of BAD and Raf-1 by Akt sensitizes human ovarian cancer cells to paclitaxel.
    Mabuchi S; Ohmichi M; Kimura A; Hisamoto K; Hayakawa J; Nishio Y; Adachi K; Takahashi K; Arimoto-Ishida E; Nakatsuji Y; Tasaka K; Murata Y
    J Biol Chem; 2002 Sep; 277(36):33490-500. PubMed ID: 12087097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis suppression by Raf-1 and MEK1 requires MEK- and phosphatidylinositol 3-kinase-dependent signals.
    von Gise A; Lorenz P; Wellbrock C; Hemmings B; Berberich-Siebelt F; Rapp UR; Troppmair J
    Mol Cell Biol; 2001 Apr; 21(7):2324-36. PubMed ID: 11259582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt.
    del Peso L; González-García M; Page C; Herrera R; Nuñez G
    Science; 1997 Oct; 278(5338):687-9. PubMed ID: 9381178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Versatility of BCR/ABL-expressing leukemic cells in circumventing proapoptotic BAD effects.
    Salomoni P; Condorelli F; Sweeney SM; Calabretta B
    Blood; 2000 Jul; 96(2):676-84. PubMed ID: 10887134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phosphatidylinositol 3-kinase-dependent pathway that differentially regulates c-Raf and A-Raf.
    Sutor SL; Vroman BT; Armstrong EA; Abraham RT; Karnitz LM
    J Biol Chem; 1999 Mar; 274(11):7002-10. PubMed ID: 10066754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCR/ABL and IL-3 activate Rap1 to stimulate the B-Raf/MEK/Erk and Akt signaling pathways and to regulate proliferation, apoptosis, and adhesion.
    Jin A; Kurosu T; Tsuji K; Mizuchi D; Arai A; Fujita H; Hattori M; Minato N; Miura O
    Oncogene; 2006 Jul; 25(31):4332-40. PubMed ID: 16518411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p21-activated Kinase 1 (Pak1)-dependent phosphorylation of Raf-1 regulates its mitochondrial localization, phosphorylation of BAD, and Bcl-2 association.
    Jin S; Zhuo Y; Guo W; Field J
    J Biol Chem; 2005 Jul; 280(26):24698-705. PubMed ID: 15849194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Bcr-Abl expression prevents the translocation of Bax and Bad to the mitochondrion.
    Keeshan K; Cotter TG; McKenna SL
    Leukemia; 2002 Sep; 16(9):1725-34. PubMed ID: 12200687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/akt: involvement of MEK upstream of Bad phosphorylation.
    Scheid MP; Duronio V
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7439-44. PubMed ID: 9636168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidylinositol 3-kinase requirement in activation of the ras/C-raf-1/MEK/ERK and p70(s6k) signaling cascade by the insulinomimetic agent vanadyl sulfate.
    Pandey SK; Théberge JF; Bernier M; Srivastava AK
    Biochemistry; 1999 Nov; 38(44):14667-75. PubMed ID: 10545192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Raf-1 alters multiple downstream pathways to induce pancreatic beta-cell apoptosis.
    Alejandro EU; Johnson JD
    J Biol Chem; 2008 Jan; 283(4):2407-17. PubMed ID: 18006502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In cardiomyocyte hypoxia, insulin-like growth factor-I-induced antiapoptotic signaling requires phosphatidylinositol-3-OH-kinase-dependent and mitogen-activated protein kinase-dependent activation of the transcription factor cAMP response element-binding protein.
    Mehrhof FB; Müller FU; Bergmann MW; Li P; Wang Y; Schmitz W; Dietz R; von Harsdorf R
    Circulation; 2001 Oct; 104(17):2088-94. PubMed ID: 11673351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of kinase cascade inhibitors on neoplastic and cytokine-mediated cell proliferation.
    Shelton JG; Moye PW; Steelman LS; Blalock WL; Lee JT; Franklin RA; McMahon M; McCubrey JA
    Leukemia; 2003 Sep; 17(9):1765-82. PubMed ID: 12970777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcr-Abl regulates osteopontin transcription via Ras, PI-3K, aPKC, Raf-1, and MEK.
    Hickey FB; England K; Cotter TG
    J Leukoc Biol; 2005 Jul; 78(1):289-300. PubMed ID: 15857938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergy between PI3K/Akt and Raf/MEK/ERK pathways in IGF-1R mediated cell cycle progression and prevention of apoptosis in hematopoietic cells.
    Shelton JG; Steelman LS; White ER; McCubrey JA
    Cell Cycle; 2004 Mar; 3(3):372-9. PubMed ID: 14726697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the RAF/MEK/ERK and PI3K/AKT signal transduction pathways on the abrogation of cytokine-dependence and prevention of apoptosis in hematopoietic cells.
    Shelton JG; Steelman LS; Lee JT; Knapp SL; Blalock WL; Moye PW; Franklin RA; Pohnert SC; Mirza AM; McMahon M; McCubrey JA
    Oncogene; 2003 Apr; 22(16):2478-92. PubMed ID: 12717425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of apoptosis in BCR/ABL+ cells by histone deacetylase inhibitors involves reciprocal effects on the RAF/MEK/ERK and JNK pathways.
    Yu C; Subler M; Rahmani M; Reese E; Krystal G; Conrad D; Dent P; Grant S
    Cancer Biol Ther; 2003; 2(5):544-51. PubMed ID: 14614324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.